Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease

Movement Disorders

Volumn 21, Issue 8, 2006, Pages 1232-1235

  Marongiu, Roberta ^a,b   Ghezzi, Daniele ^c   Ialongo, Tamara ^d   Soleti, Francesco ^d   Elia, Antonio ^d   Cavone, Stefania ^a   Albanese, Alberto ^d   Altavista, Maria Concetta ^e   Barone, Paolo ^f   Brusa, Livia ^g   Cortelli, Pietro ^h   Petrozzi, Lucia ⁱ   Scaglione, Cesa ^h   Stanzione, Paolo ^j   Tinazzi, Michele ^k   Zeviani, Massimo ^c   Dallapiccola, Bruno ^a,b   Bentivoglio, Anna Rita ^d   Valente, Enza Maria ^a,b   Garavaglia, Barbara ^c   Conca, Elena ^l   Fasano, Alfonso ^l   Marelli, Cecilia ^l   Martinelli, Paolo ^l   Nordera, Giampietro ^l   Pellecchia, Maria Teresa ^l   more..

^a Mendel Institute   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e SAN FILIPPO NERI HOSPITAL   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g S EUGENIO HOSPITAL   (Italy)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ UNIVERSITY OF PISA   (Italy)

^j UNIVERSITY OF ROME TOR VERGATA   (Italy)

^k UNIVERSITY OF VERONA   (Italy)

^l NONE

more..

Author keywords

Dardarin; Italy; LRRK2; Mutation screening; Parkinson's disease

Indexed keywords

GENE PRODUCT; LEUCINE RICH REPEAT KINASE 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CONTROLLED STUDY; DISEASE DURATION; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HAPLOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SUBSTITUTION; FEMALE; GENE FREQUENCY; HETEROZYGOTE DETECTION; HUMANS; ITALY; MALE; MUTATION; PARKINSON DISEASE; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES;

EID: 33748347105     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20890     Document Type: Article

References (10)

1. Gasser T. Genetics of Parkinson's disease. Curr Opin Neurol 2005;18:363-369.
2. Nichols WC, Pankratz N, Hernandez D, et al. Genetic screening for a single -common LRRK2 mutation in familial Parkinson's disease. Lancet 2005;365:410-412.
3. Di Fonzo A, Rohe CF, Ferreira J, et,al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 2005;365:412-415.
4. Gilks WP, Abou-Sleiman PM, Gandhi S, et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005;365,:415-416.
5. Kachergus J, Mata IF, Hulihan M, et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 2005;76:672-680.
6. Aasly JO, Toft M, Fernandez-Mata I, et al. Clinical features of LRRK2-associated Parkinson's disease in central Norway. Ann Neurol 2005;57:762-765.
7. Farrer M, Stone J, Mata IF, et al. LRRK2 mutations in Parkinson disease. Neurology 2005,65:738-740.
8. Deng H, Le W, Guo Y, Hunter CB, Xie W, Jankovic J. Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation. Ann Neurol 2005;57:933-934.
9. Lesage S, Leutenegger AL, Ibanez P, et al. LRRK2 haplotype analyses in European and North African families with Parkinson disease: a mutation dating from the 13th Century. Am J Hum Genet 2005;77:330.
10. Paisan-Ruiz C, Lang AE, Kawarai T, et al. LRRK2 gene in Parkinson's disease. Mutation analysis and case control association study. Neurology 2005,65:696-700.